SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma gets USFDA nod for Levofloxacin Injection

25 Jan 2013 Evaluate

Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Levofloxacin Injection, 25mg/mL, packaged in 500mg/20mL and 750mg/30mL Single-use Vials.

Levofloxacin Injection, 25mg/mL packaged in 500mg/20mL and 750mg/30mL Single-use Vials is the generic equivalent of Janssen Pharmaceuticals Inc.’s Levaquin Injection 25mg/mL and indicated for the treatment of adults with mild, moderate, and severe infections caused by susceptible isolates of the designated microorganisms such as Pneumonia. Acute Bacterial Sinusitis or Complicated Urinary Tract Infections etc and intravenous administration offers a route of administration advantageous to the patient. 

These ANDAs have been approved out of Unit IV formulation facility in Hyderabad, India for manufacturing general liquid injectable and ophthalmic products and will be marketed and sold by Aurobindo's US subsidiary AuroMedics Pharma LLC.

Aurobindo now has a total of 175 ANDA approvals (150 Final approvals including 2 from Aurolife Pharma LLC and 25 Tentative approvals) from USFDA.

Aurobindo Pharma Share Price

1548.85 -6.10 (-0.39%)
29-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1872.60
Dr. Reddys Labs. 1376.30
Cipla 1453.50
Zydus Lifesciences 1121.65
Lupin 2407.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: